Skip to content
Screener

Precigen PGEN Operating margin

Operating margin at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
24.7%-2.3pp
Gilead Sciences logo
Gilead SciencesGILD
-8.2%-36.1pp
Allogene Therapeutics logo
Allogene TherapeuticsALLO
-1,241,813.6%-2,018,140pp
Regenxbio logo
RegenxbioRGNX
-94.1%-9.3pp
Opko Health logo
Opko HealthOPK
-8.2%-3.5pp
Arrowhead Research logo
Arrowhead ResearchARWR
-35.7%+63.6pp

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.47B+358%
Enterprise value$2.56B+382%
P/S93.2×—

Profitability

See full
Gross margin83.6%—
Net margin-3,656%—
FCF margin-1,756.5%—

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×—
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

operating income/total revenue=-2,890.9%

Based on trailing twelve months.

The source filing: Precigen’s 10-Q, filed May 13, 2026. Open the filing →

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017

FAQ

What is Precigen's operating margin?
Precigen (PGEN) reported operating margin of -2,890.9% in Q1 2025.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Ask your AI about Precigen's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude